MYOVANT SCIENCES LTD.

(MYOV)
  Rapport
Temps Différé Nyse  -  27/05 22:01:52
10.84 USD   +8.08%
16/05Myovant Sciences ouvre un laboratoire et un siège social à Philadelphie ; les actions augmentent
MT
10/05Earnings Flash (MYOV) MYOVANT SCIENCES rapporte des revenus de 57.6M$ pour le T4
MT
10/05Myovant Sciences Ltd. annonce ses résultats pour le quatrième trimestre clos le 31 mars 2022
CI
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur MYOVANT SCIENCES LTD.
16/05Myovant Sciences Opens Laboratory, HQ in Philadelphia; Shares Rise
16/05Spirovant Launches State-of-the-Art Laboratory and Headquarters
16/05Urovant Sciences presents new data from EMPOWUR study, advancing knowledge of the treat..
16/05Urovant Sciences Presents Interim Data from Phase 2a Study of Investigational Novel Gen..
11/05MYOVANT SCIENCES LTD. Management's Discussion and Analysis of Financial Condition and ..
10/05Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to ..
10/05TRANSCRIPT : Myovant Sciences Ltd., Q4 2022 Earnings Call, May 10, 2022
10/05MYOVANT SCIENCES : Fiscal Q4 Earnings Snapshot
10/05Earnings Flash (MYOV) MYOVANT SCIENCES Reports Q4 Revenue $57.6M
10/05Myovant Sciences Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2..
10/05Myovant Sciences Announces Corporate Updates and Financial Results for Fourth Fiscal Qu..
10/05Myovant Sciences Ltd. Reports Earnings Results for the Full Year Ended March 31, 2022
09/05Myovant Sciences Enters European License Deal With Accord Healthcare for Prostate Cance..
09/05Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) ..
09/05Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to ..
09/05Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to ..
09/05Myovant Sciences and Accord Healthcare, Ltd. Enter into Exclusive License Agreement to ..
06/05Myovant, Pfizer Say FDA Extends Review Period for Myfembree's Supplemental New Drug App..
06/05Altavant sciences presents data showing potential for combination of rodatristat ethyl ..
06/05Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) ..
06/05Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application (sNDA) ..
06/05MYOVANT, PFIZER : FDA Extends Review of Myfembree in Endometriosis
02/05Altavant sciences presented data at ishlt showing potency and distribution of bronchiol..
02/05Myovant Sciences' Prostate Cancer Drug Receives European Commission Approval
30/04Myovant Sciences Announces European Commission Approval for ORGOVYX® (relugolix) for th..
30/04Myovant Sciences Announces European Commission Approval for ORGOVYX® (relugolix) for th..
30/04Myovant Sciences Ltd. Announces European Commission Approval for Orgovyx for the Treatm..
26/04MYOVANT SCIENCES TO HOST FOURTH FISC : 30 a.m. Eastern Time on May 10, 2022
20/04Urovant Sciences Announces Publication of EMPOWUR Trial Subgroup Analysis Showing Simil..
14/04Urovant Sciences to Present Interim Data from Phase 2a Study of Potential Novel Gene Th..
13/04Sumitomo Pharma Co., Ltd. - Myovant Sciences and Pfizer Provide Update on Supplemental ..
13/04Sumitomo Dainippon Unit's New Drug Application with US FDA Hits Roadblock
12/04Kohl's, PG&E rise; CarMax, Myovant fall
12/04SECTOR UPDATE : Health Care Stocks Ending Near Intra-Day Lows
12/04Pfizer, Myovant Sciences Stocks Drop After FDA Flags Deficiencies in Supplemental New D..
12/04Top Midday Decliners
12/04SECTOR UPDATE : Health Care Stocks Drifting Lower Tuesday Afternoon
12/04SECTOR UPDATE : Health Care
12/04GLOBAL MARKETS LIVE : Honda, Shopify, Meta, ASOS, Gilead Sciences...
12/04Myovant Sciences Stock Hits 52-Week Low After FDA Notice for Myfembree
12/04Inflation data ease investors' fears
12/04Wall Street Set for Gains; Consumer Prices Accelerate in March
12/04SECTOR UPDATE : Health Care Stocks Higher Premarket Tuesday
12/04SECTOR UPDATE : Health Care
12/04Myovant Sciences Shares Drop 20% After FDA Notice for Myfembree
12/04Top Premarket Decliners
12/04Pfizer, Myovant Sciences Say FDA Flags Certain Deficiencies in Supplemental New Drug Ap..
12/04Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application for MYF..
25/03MYOVANT SCIENCES LTD. : Change in Directors or Principal Officers, Financial Statements an..
08/03TRANSCRIPT : Myovant Sciences Ltd. Presents at 42nd Annual Cowen Health Care Conference, M..
25/02Myovant Sciences Receives Positive European Medicines Agency Opinion for Orgovyx to Tre..
25/02Myovant Sciences Receives Positive CHMP Opinion for ORGOVYX® (relugolix) for the Treatm..
25/02Myovant Sciences Receives Positive CHMP Opinion for Orgovyx® for the Treatment of Advan..
18/02TRANSCRIPT : Myovant Sciences Ltd. Presents at 11th SVB Leerink Annual Global Healthcare C..
10/02Sumitomo Dainippon Pharma and Sumitovant Biopharma Initiate Phase 1 Study on New Drug C..
07/02Myovant Sciences to Present at Upcoming Investor Conferences
26/01TRANSCRIPT : Myovant Sciences Ltd., Q3 2022 Earnings Call, Jan 26, 2022
26/01MYOVANT SCIENCES : Fiscal Q3 Earnings Snapshot
26/01Myovant Sciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months En..
26/01Myovant Sciences Fiscal Q3 Loss Narrows, Revenue Climbs
26/01MYOVANT SCIENCES : Announces Financial Results for Third Quarter of Fiscal Year 2021 and C..
26/01MYOVANT SCIENCES LTD. : Results of Operations and Financial Condition (form 8-K)
26/01Earnings Flash (MYOV) MYOVANT SCIENCES Reports Q3 Revenue $54.4M
26/01Myovant Sciences Announces Financial Results for Third Quarter of Fiscal Year 2021 and ..
12/01TRANSCRIPT : Myovant Sciences Ltd. Presents at JPMorgan 40th Annual Healthcare Conference,..
12/01MYOVANT SCIENCES TO HOST THIRD FISCA : 30 a.m. Eastern Time on January 26, 2022
10/01MYOVANT SCIENCES : Announces Preliminary Financial Results for Third Quarter of Fiscal Yea..
10/01Myovant Sciences Announces Preliminary Financial Results for Third Quarter of Fiscal Ye..
10/01Myovant Sciences Ltd. Provides Revenue Guidance for the Three Months Ended December 31,..
03/01Myovant Sciences to Present at the 40th Annual J.P. Morgan Healthcare Conference
2021Myovant Sciences to Participate in the Evercore ISI 4th Annual HealthCONx Conference
2021MYOVANT SCIENCES LTD. : Change in Directors or Principal Officers, Submission of Matters t..
2021Myovant Sciences Ltd. Announces Kathleen Sebelius Does Not Stand for Re-Election
2021Nancy Valente, M.D. Joins Myovant Sciences' Board of Directors
2021Myovant Sciences Appoints Nancy Valente as Independent Member of its Board of Directors..
1  2  3  4  5  6Suiv.
Prochain événement sur MYOVANT SCIENCES LTD.